- An Opioid Treatment Program (OTP) clinic stores its bulk methadone for dispensing. Due to the high volume and concentration of this Schedule II substance, OTPs are subject to more stringent security standards than a typical community pharmacy. Which of the following best represents one of these enhanced security requirements?
Answer: The facility must have a DEA-approved safe or steel cabinet of a certain class rating for burglary resistance.
While standard pharmacies need a 'substantially constructed cabinet,' federal regulations for OTPs (42 CFR Part 8) and DEA guidance require a higher level of physical security. This often includes specifications for the class of safe (e.g., a UL-rated tool-resistant or torch-resistant safe), reflecting the greater risk associated with large quantities of liquid opioids. The other options are good operational practices but the specific requirement for a rated safe (B) is a key enhanced security measure.
- A community pharmacy utilizes an automated dispensing system (robot) for its fast-moving medications, which is not independently self-locking. This system stocks several Schedule III and IV products. To comply with federal storage regulations for these controlled substances, the Pharmacist-in-Charge (PIC) must ensure which security measure is in place?
Answer: The automated dispensing system is located within a securely locked room or enclosure that restricts access to authorized pharmacy personnel.
Under 21 CFR § 1301.75, Schedule III-V substances must be stored in a securely locked, substantially constructed cabinet or dispersed throughout the non-controlled stock. Since a robot concentrates the medications and is not considered 'dispersed,' and the unit itself is not self-locking, the robot must be housed within a secure area (like a locked room) to meet the storage requirement. The other options are either insufficient (B, C) or incorrect (D).
- The Pharmacist-in-Charge (PIC) at a pharmacy grants a Power of Attorney (POA) to a trusted staff pharmacist to execute DEA Form 222s. The POA is properly executed and filed at the pharmacy. Two years later, the pharmacy's DEA registration is renewed. What is the status of the staff pharmacist's POA?
Answer: The POA remains valid indefinitely until it is formally revoked by the registrant or the grantee leaves employment.
A Power of Attorney for DEA forms is not tied to the registration period and does not expire automatically. It remains in effect as long as the grantee remains employed at that registrant, or until the person who granted the POA (the registrant or their authorized representative) revokes it. It does not need to be re-executed or re-filed upon DEA registration renewal.
- A community pharmacy stores its Schedule II drugs in a locked safe and disperses its Schedule III-V drugs throughout the non-controlled stock. During a renovation, the pharmacy must temporarily move its entire stock to a secured trailer in the parking lot for one week. The trailer has a single, high-security lock. To remain compliant with federal storage requirements, what must the pharmacy do?
Answer: Keep the C-IIs locked in a cabinet inside the trailer and disperse the C-III-Vs among the non-controlled stock inside the trailer.
The DEA storage requirements do not change based on location. Even in a temporary setting, Schedule II drugs must be in a securely locked, substantially constructed cabinet (or safe/vault). Schedule III-V drugs may either be locked up or dispersed. Dispersing C-IIs (B) is never allowed. Placing all controls in one cabinet (A) is an option, but not the only one. D correctly identifies that the existing, compliant storage system can be replicated within the secure temporary location.
- An institutional pharmacy is storing a new investigational analgesic being studied under an Investigational New Drug (IND) application. The drug has been classified as a Schedule II controlled substance. How must this investigational drug be stored within the pharmacy?
Answer: It must be stored in a securely locked, substantially constructed cabinet, physically separate from all other regularly stocked controlled substances.
Investigational drugs that are also controlled substances must adhere to all DEA regulations for their assigned schedule, including storage in a locked safe or cabinet for C-IIs. Additionally, to prevent medication errors, investigational drugs must be stored separately from commercially available stock. Option B is the only one that meets both of these critical requirements.
- A pharmacy director is considering hiring a technician who, five years prior, was convicted of a misdemeanor for illegally possessing a controlled substance. According to DEA regulations, what must the pharmacy director do before allowing this individual to work in a position with access to controlled substances?
Answer: The director must apply for and be granted a waiver for that specific employee from the DEA.
Under 21 CFR § 1301.76, a DEA registrant shall not employ any person who has been convicted of an offense relating to controlled substances in a position with access to them. However, the registrant may request an exception (waiver) to this prohibition from the DEA. Hiring without a waiver (D) or simply restricting duties (C) is not compliant. The prohibition is not absolute if a waiver is obtained (A).
- A community pharmacy maintains a collection receptacle (take-back bin) for unwanted patient medications. Which of the following is a mandatory security and procedural requirement for managing the contents of this receptacle?
Answer: The inner liner must be removed from the receptacle and sealed immediately by two qualified employees.
DEA regulations (21 CFR § 1317.60) specify the process for collection receptacles. A key security step is that when the inner liner is removed, it must be done by or under the supervision of at least two employees, and it must be sealed immediately upon removal, before being stored in a secure area. This 'two-person integrity' is a critical control point. The other options describe common practices or misinterpret the specific regulations.
- A pharmacist identifies a shortage of 10 tablets of oxycodone 10 mg (C-II) and 25 tablets of zolpidem 10 mg (C-IV) during a routine count. When determining if this constitutes a 'significant loss' that requires reporting to the DEA via Form 106, which is the most critical factor for the pharmacist to consider?
Answer: The actual and relative abuse potential and diversion risk of the missing substances.
The DEA does not provide a specific quantity that defines a 'significant loss.' Instead, the registrant must consider several factors. The most important of these is the nature of the drug itself. The loss of a small number of a highly sought-after C-II like oxycodone is generally more significant than a larger loss of a C-IV. Therefore, the abuse potential and diversion risk of the specific drugs are the most critical considerations. The other factors are relevant but secondary to the type of substance.
- A pharmacy technician accepts a medication delivery from a wholesaler. The delivery includes a sealed tote marked 'C-II' that requires a signature. After signing for the entire delivery, what is the technician's most appropriate immediate action regarding this specific tote?
Answer: Immediately move the sealed tote into the pharmacy's locked safe or cabinet where other Schedule II medications are kept.
Upon receipt, Schedule II controlled substances must be immediately secured to prevent diversion or theft. The most appropriate action is to move the sealed tote directly into the approved secure storage location (safe, cabinet, etc.) until a pharmacist can verify its contents. Leaving it in a general check-in area (B) is less secure. The pharmacist does not need to stop their work immediately to check it in (D), and the driver does not need to wait (A); the pharmacy's responsibility begins upon signing for the delivery.
- A fire alarm requires the immediate evacuation of the pharmacy. At the moment the alarm sounds, a technician is counting a 500-count stock bottle of morphine sulfate ER on the counter. What is the pharmacist's most appropriate instruction to the technician?
Answer: Immediately place the bottle, lid, and loose tablets into the C-II safe if it can be done in seconds, then evacuate.
While life safety is the absolute priority, a pharmacist also has a responsibility to secure dangerous drugs. If a large quantity of a C-II can be secured in a few seconds without delaying evacuation, it is the most responsible action. This balances safety with the professional duty to prevent diversion. Leaving it unsecured (C) creates a significant public safety risk. Taking it during an evacuation (A) is unsafe and risks losing it. Covering it (D) offers no real security.
- A pharmacist consultant is reviewing medication storage on a nursing unit in a Long-Term Care Facility (LTCF). Nurses use a medication cart that is frequently moved along a hallway during medication administration rounds. What is the most fundamental federal security requirement for the controlled substances stored within this cart?
Answer: The cart must be securely locked whenever it is not within the immediate control and sight of the authorized nurse.
The primary security principle for mobile storage units like medication carts is that they must be secured to prevent unauthorized access when not attended. The requirement to lock the cart when not under the direct, immediate control of the authorized personnel is a fundamental security standard. While other options like double-locking (A) or packaging (D) may be state requirements or best practices, the constant securing of the cart (B) is the most critical and universal principle.
- A pharmacist mails a completed DEA Form 222 to a wholesaler to order a supply of fentanyl patches. After two weeks, the wholesaler informs the pharmacist that the form was never received. According to federal regulations, what is the pharmacist's required course of action?
Answer: Execute a new DEA Form 222 and send it to the wholesaler with an attached statement about the lost original form.
According to 21 CFR § 1305.16, if a purchaser determines that an unfilled DEA Form 222 has been lost, they must execute another form and attach a statement to it. This statement must include the serial number and date of the lost form and a declaration that the goods from the first order were not received. A copy of this statement is retained with the copy of the lost form.
- A mail-order pharmacy is preparing to ship a 30-day supply of hydromorphone to a patient's home using a common carrier. To ensure security and compliance with federal regulations regarding the mailing of controlled substances, the outer packaging of the shipment must be:
Answer: plainly packaged, with no markings on the outside that would indicate the contents are medications.
Federal regulations (incorporating U.S. Postal Service rules) require that the outer container or wrapper of a mailed controlled substance be free of markings that would indicate the nature of the contents. This is a security measure to avoid drawing attention to the package and prevent theft. Any special markings (B), unusual addressing (C), or non-existent DEA tape (D) would violate this requirement.
- A new pharmacy is being constructed inside a large supermarket. The supermarket is open 24 hours, but the pharmacy will only be staffed from 9 AM to 9 PM. According to common state laws and security principles, which design feature is essential for this pharmacy?
Answer: A floor-to-ceiling physical barrier enclosing the pharmacy department, with all entry points securely locked when closed.
For a pharmacy located within a larger retail establishment that has different hours, the pharmacy must be a secure, self-contained unit when closed. This requires a physical barrier, typically from the floor to the ceiling, to prevent access to the prescription drugs and patient information. The other options are either not required (A, C) or would be a major security violation (D).
- A central fill pharmacy processes and packages prescriptions, including Schedule II substances, for a chain of retail pharmacies. After verification, prescriptions are placed in sealed bags and stored in totes awaiting courier pickup. Which security measure is required for the totes containing filled C-II prescriptions while stored at the central fill facility?
Answer: The totes must be stored inside a securely locked, substantially constructed cabinet, safe, or vault.
Even though the Schedule II substances have been dispensed into patient-specific packaging, they are still controlled substances under the pharmacy's responsibility until they leave the facility. Therefore, they must be stored according to C-II security requirements, which mandate storage in a securely locked cabinet, safe, or vault. Surveillance (A), supervision (C), and tamper-evident tape (D) are good practices but do not replace this fundamental physical security requirement.
- A pharmacy stores its Schedule II controlled substances in a heavy-gauge steel cabinet with a double-bolt lock. The cabinet is located in the main pharmacy area but is not bolted to the wall or floor. During a Board of Pharmacy inspection, this arrangement is most likely to be cited as a violation if:
Answer: the cabinet weighs less than 750 pounds.
According to 21 CFR § 1301.75, a safe or steel cabinet for storing C-IIs must either be bolted to the floor or wall or be of sufficient weight and construction to deter theft. The commonly accepted standard is that if the safe/cabinet weighs less than 750 lbs., it must be bolted down. The other options describe practices that are either permissible (B, C) or not required (D).
- The sole pharmacist at an independent community pharmacy closes the prescription department for a 30-minute lunch break. The front-end of the store, staffed by a clerk, remains open. What is the minimum security requirement for the prescription department during this break?
Answer: The prescription department must be secured by a physical barrier, such as a locked door or gate, to prevent unauthorized entry.
When a pharmacist is not on duty, the pharmacy must be secured to prevent unauthorized access. The fundamental requirement, common to nearly all state laws, is a physical barrier that prevents entry into the prescription filling and storage area. While other options may be good practice or required by some states (e.g., remaining on premises), the physical barrier is the most universal and essential security measure.
- A pharmacist arrives in the morning and discovers the pharmacy's back door lock was broken overnight. A comprehensive inventory of all controlled substances is immediately performed with law enforcement present, and it confirms that no medications are missing. Which action is the pharmacy required to take?
Answer: Notify the state board of pharmacy and the local DEA Diversion Field Office about the attempted break-in.
A DEA Form 106 is for reporting the actual theft or significant loss of controlled substances. Since no drugs were missing, filing Form 106 would be inappropriate. However, an attempted break-in represents a serious breach of security that must be reported to the relevant regulatory bodies, namely the state board and the DEA. Simply documenting it internally (C) is insufficient due to the severity of the event.
- A pharmacist is organizing controlled substance records. According to federal law, where must the pharmacy's executed DEA Form 222s and biennial inventory records be kept?
Answer: They must be kept at the DEA-registered location and be separate from all other pharmacy records.
Federal law (21 CFR § 1304.04) requires that certain records, including executed DEA Form 222s and inventories, must be maintained at the registered location. They cannot be kept at a central location (B). Furthermore, they must be kept separate from all other records of the registrant. Storing them with other prescriptions (D) or in the safe (A) is not the specific legal requirement; the key is that they are at the registered site and stored separately.
